초록

Voriconazole and fluconazole are azole antifungal agents which the 2010 IDSA (Infectious Diseases Society of America) guideline of cancer neutropenic fever has recommended to use for fungal prophylaxis in hematopoietic stem cell transplantation. However, these agents are known to have an interaction with immunosuppressants such as calcineurin inhibitors, and to elevate the serum calcineurin inhibitors level. The goal of this study was to compare the drug interaction between voriconazole and cyclosporine with fluconazole and cyclosporine. Further,the we compared the renal function after the drug interactions. Fifty-nine patients were enrolled in this study from January 2007 to August 2011. Eleven patients received voriconazole, and forty-eight patients received fluconazole. In this study, there is a difference in cyclosporine dose among patients hence, we calculated the C/D ratio [(ng/mL)/(mg/kg)]. C/D ratio is represented as the serum trough level of cyclosporine when it is administered 1 mg/kg in patients. Peak day means the day that the C/D ratio reaches its peak value. The C/D ratio of the voriconazole group was 209.90±176.38 [(ng/mL)/(mg/kg)] and was higher than 129.36±38.20[(ng/mL)/(mg/kg)], the value of the fluconazole group. However, the peak day of the voriconazole group was 14.82±7.96 days and was slower than that of the fluconazole group. The alteration of the renal function test value was higher in the voriconazole group. Howerer, only BUN showed a significant difference between the two groups. There was no correlation between the C/D ratio and renal panel.

키워드

Cyclosporine, Voriconazole, Fluconazole, Allogenic hematopoietic stem cell transplantation

참고문헌(22)open

  1. [학술지] Wingard J.R. / 1990 / Advances in the management of infectious complications after bone marrow transplantation / Bone Marrow Transplant 6 (6) : 371

  2. [기타] / 2010 / 2010 ISDA guideline , Clinical practice guideline for the use antimicrobial agent in neutropenic patient with cancer : 2010 update guideline

  3. [학술지] Eyal Robenshtok / 2007 / Antifungal prophylaxis in Cancer patients after chemotherapy or hematopoietic stem cell transplantation: systemic review and meta analysis / J Clin Oncol 25 : 5471 ~ 5489

  4. [학술지] Livio Pagano / 2010 / Current therapeutic approaches to fungal infections in immunocompromised hematological patients / Blood Reviews 24 : 51 ~ 61

  5. [학술지] John R. Wingard / 2010 / Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogenic hematopoietic cell transplantation / Blood 116 : 5111 ~ 5118

  6. [기타] / Micromedex- Voriconazole Drug information

  7. [기타] / Micromedex- Fluconazole Drug information

  8. [학술지] T. Mori / 2009 / Drug interaction between voriconazole and calcineurin inhibitors in allogenic hematopoietic stem cell transplantation recipients / Bone Marrow Transplantation 44 : 371 ~ 374

  9. [학술지] H.L. Leather / 2004 / Drug interactions in the hematopoietic stem cell transplant (HSCT) recipient : what every transplanter needs to know / Bone Marrow Transplantation 33 : 137 ~ 152

  10. [학술지] Paul O. Gubbins / Mould-active azoles: pharmacokinetics, drug interactions in neutropenic patients / Curr Opin Infect Dis 20 : 579 ~ 586

  11. [학술지] Andreas H. Groll / 2004 / Pharmacokinetic interaction between voriconazole and cyclosporine A following allogenic bone marrow transplantation / Journal of Antimicrobial Chemotherapy 53 : 113 ~ 114

  12. [학술지] Hitoshi Kawazoe / 2006 / Change of the blood concentration of tacrolimus after the switch from fluconazole to voriconazole in patients receiving allogenic hematopoietic stem cell transplantation / Biol. Pharm. Bull 29 (12) : 2528 ~ 2531

  13. [학술지] Ai Mihar / 2008 / Greater impact of oral fluconazole on drug interaction with intravenous calcineurin inhibitor as compared with intravenous fluconazole / Eur J Clin Pharmacol 64 : 89 ~ 91

  14. [학술지] S.M. Trifilio / 2007 / Tacrolimus use in adult allogeneic stem cell transplant recipient receiving voriconazole: preemptive dose modification and therapeutic drug monitoring / Bone Marrow Transplantation 40 : 451 ~ 456

  15. [기타] / Micromedex- Cyclosporine Drug information

  16. [학술지] Steven Gabardi / 2007 / Factor influencing the magnitude and clinical significance of drug interaction between azole antifungal and select immunosuppressant / Pharmacotherapy 27 (4) : e3 ~ e6

  17. [학술지] Alain J. Romero / 2002 / Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patient / Clinical pharmacology and Therapeutics 71 (4) : 226 ~ 234

  18. [학술지] 김승은 / 2009 / 장기 이식 환자에서 voriconazole과 cyclosporine 또는 tacrolmus의 상호작용 / 병원약사회지 26 (1) : 35 ~ 42

  19. [학술지] S. Kimura / 2010 / Pharmacokinetics of CsA during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation / Bone Marrow Transplantation 45 : 1088 ~ 1094

  20. [학술지] Schrauder A. / 2009 / Pharmacokinetic monitoring of intravenous cyclosporine A in pediactric stem-cell transplant recipients / Pediatric Transplantation 13 : 444 ~ 450

  21. [학술지] Chirag R. Parikh / 2002 / Renal dysfunction in allogeneic hematopoietic cell transplantation / Kidney Int 62 (2) : 566

  22. [학술지] Sangeeta R. / 2005 / Acute renal failure after myeloablative hematopoietic cell transplant: incidence and risk factors / Kidney Int 67 (1) : 272